Mariner, LLC 10x Genomics, Inc. Transaction History

Mariner, LLC

$51.1 Billion
Q2 2024

A detailed history of Mariner, LLC transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Mariner, LLC holds 13,550 shares of TXG stock, worth $219,103. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,550

Previous 18,387 26.31%

Holding current value

$219,103

Previous $690,000 61.88%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$19.45 - $37.37 $94,079 - $180,758	-4,837 Reduced 26.31%	13,550 $263,000
Q1 2024 May 15, 2024	BUY	$36.08 - $54.3 $35,574 - $53,539	986 Added 5.67%	18,387 $690,000
Q4 2023 Feb 14, 2024	SELL	$34.32 - $57.55 $7,104 - $11,912	-207 Reduced 1.18%	17,401 $973,000
Q3 2023 Nov 13, 2023	BUY	$40.86 - $62.98 $10,501 - $16,185	257 Added 1.48%	17,608 $726,000
Q2 2023 Aug 11, 2023	BUY	$50.96 - $58.72 $10,803 - $12,448	212 Added 1.24%	17,351 $968,000
Q1 2023 May 12, 2023	SELL	$35.33 - $55.79 $39,746 - $62,763	-1,125 Reduced 6.16%	17,139 $954,000
Q4 2022 Feb 14, 2023	BUY	$24.4 - $41.3 $98,063 - $165,984	4,019 Added 28.21%	18,264 $666,000
Q3 2022 Nov 10, 2022	BUY	$28.48 - $52.59 $35,286 - $65,159	1,239 Added 9.53%	14,245 $406,000
Q2 2022 Aug 15, 2022	BUY	$36.95 - $82.41 $480,571 - $1.07 Million	13,006 New	13,006 $589,000
Q1 2022 May 13, 2022	SELL	$55.7 - $145.79 $654,920 - $1.71 Million	-11,758 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$135.05 - $182.59 $335,599 - $453,736	-2,485 Reduced 17.45%	11,758 $1.75 Million
Q3 2021 Nov 15, 2021	SELL	$145.58 - $192.14 $134,515 - $177,537	-924 Reduced 6.09%	14,243 $2.07 Million
Q2 2021 Aug 24, 2021	BUY	$134.22 - $202.37 $2.04 Million - $3.07 Million	15,167 New	15,167 $2.97 Million

Others Institutions Holding TXG

# of Institutions

287

Shares Held

94.9M

Call Options Held

162K

Put Options Held

107K

View Full List

About 10x Genomics, Inc.

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.54B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

More about TXG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mariner, LLC with notifications on news.

Account